Correction to: Comparative efficacy of Umeclidinium/Vilanterol versus other bronchodilators for the treatment of chronic obstructive pulmonary disease: A network meta-analysis.

Ismaila, AS; Haeussler, K; Czira, A; Tongbram, V; Malmenäs, M; Agarwal, J; Nassim, M; Živković-Gojović, M; Shen, Y; Dong, X; Duarte, M; Compton, C; Vogelmeier, CF; Halpin, DMG

dc.contributor.author	Ismaila, AS
dc.contributor.author	Haeussler, K
dc.contributor.author	Czira, A
dc.contributor.author	Tongbram, V
dc.contributor.author	Malmenäs, M
dc.contributor.author	Agarwal, J
dc.contributor.author	Nassim, M
dc.contributor.author	Živković-Gojović, M
dc.contributor.author	Shen, Y
dc.contributor.author	Dong, X
dc.contributor.author	Duarte, M
dc.contributor.author	Compton, C
dc.contributor.author	Vogelmeier, CF
dc.contributor.author	Halpin, DMG
dc.date.accessioned	2023-06-21T10:12:11Z
dc.date.issued	2022-09-02
dc.date.updated	2023-06-20T08:56:06Z
dc.description.abstract	The authors regret to inform readers that the labels for the ‘treatment favour’ arrows were incorrectly labelled in Fig. 4. The ‘Favours UMEC/VI 62.5/25’ and ‘Favours comparator’ labels were appended to the wrong arrows and the corrected Fig. 4 is shown below. Please note that the data have not changed between versions.	en_GB
dc.format.extent	5011-5012
dc.identifier.citation	Vol. 39, No. 11, pp. 5011-5012	en_GB
dc.identifier.doi	https://doi.org/10.1007/s12325-022-02288-x
dc.identifier.uri	http://hdl.handle.net/10871/133450
dc.identifier	ORCID: 0000-0003-2009-4406 (Halpin, David MG)
dc.language.iso	en	en_GB
dc.publisher	Springer	en_GB
dc.relation.url	https://www.ncbi.nlm.nih.gov/pubmed/36056291	en_GB
dc.relation.url	http://hdl.handle.net/10871/133448	en_GB
dc.rights	© Springer Healthcare Ltd., part of Springer Nature 2022. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.	en_GB
dc.title	Correction to: Comparative efficacy of Umeclidinium/Vilanterol versus other bronchodilators for the treatment of chronic obstructive pulmonary disease: A network meta-analysis.	en_GB
dc.type	Article	en_GB
dc.date.available	2023-06-21T10:12:11Z
dc.identifier.issn	0741-238X
exeter.place-of-publication	United States
dc.description	This is the final version. Available from Springer via the DOI in this record.	en_GB
dc.description	The article to which this is the correction is available in ORE at http://hdl.handle.net/10871/133448
dc.identifier.eissn	1865-8652
dc.identifier.journal	Advances in Therapy	en_GB
dc.relation.ispartof	Adv Ther, 39(11)
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/	en_GB
dcterms.dateAccepted	2022
rioxxterms.version	VoR	en_GB
rioxxterms.licenseref.startdate	2022-11
rioxxterms.type	Journal Article/Review	en_GB
refterms.dateFCD	2023-06-21T10:07:07Z
refterms.versionFCD	VoR
refterms.dateFOA	2023-06-21T10:12:17Z
refterms.panel	A	en_GB
refterms.dateFirstOnline	2022-09-02

Files in this item

Name:: Correction to Comparative Efficacy ...
Size:: 361.5Kb
Format:: PDF
Description:: Correction to: Comparative ...

View/Open

This item appears in the following Collection(s)

Clinical and Biomedical Sciences

Show simple item record

© Springer Healthcare Ltd., part of Springer Nature 2022. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

Except where otherwise noted, this item's licence is described as © Springer Healthcare Ltd., part of Springer Nature 2022. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

Show Statistical Information